Volume 9 - Issue 1 - January 2012
Case Report »
Repair of a Left Brachial Artery Pseudoaneurysm After Blood Donation in a 17-Year-Old Male
Cynthia Weber, MD, Robert Craig, MD, Ross Milner, MD
Abstract
We present a rare case report of a 17-year-old male who developed a brachial artery pseudoaneurysm after donating blood at his high school blood drive. We describe our operative approach and review the literature on the risks of blood donation and incidence of brachial artery pseudoaneurysms.
VASCULAR DISEASE MANAGEMENT 2012;9(1):E1–E2
Case Files with Dr. George »
Popliteal Artery Aneurysm Repair Using a Covered Stent Graft Reinforced with Interwoven Nitinol Stent
Vincent Varghese, MD, Richard Kovach, MD, Jon C. George, MD
Abstract
Popliteal artery aneurysm (PAA) is the most commonly encountered peripheral arterial aneurysm in vascular medicine. Surgical correction has been the gold standard of therapy with endovascular techniques using covered stent grafts having comparable medium-term patency rates.
Endovascular Techniques »
When and How to Use Proximal Occlusion Devices During Carotid Artery Angioplasty and Stenting
David Orion, MD1,3, Adnan H. Siddiqui, MD1-3, Elad I. Levy, MD1-3, L. Nelson Hopkins, MD1-3
Abstract
Methods of cerebral embolic protection during carotid artery stenting focusing on the newest method, proximal occlusion, are discussed in this manuscript. Proximal occlusion devices achieve cerebral protection through flow reversal from the internal carotid artery into the arterial guide sheath that is the conduit for the deployment of devices across the carotid bifurcation.
Interview »
Q&A with Dr. Michael Werk, of Martin Luther Hospital, About Femoropopliteal Lesions and the PACIFIER Trial
Interview by Amanda Wright
Tell me about the recent Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis (PACIFIER) Trial and its significance for patients with femoropopliteal lesions.
The PACIFIER Trial evaluated prevention of restenosis with paclitaxel-coated PTA balloon catheters in stenosis or occlusion of femoropopliteal arteries versus a control group treated with uncoated balloons. We specifically looked at the In.Pact Pacific drug-eluting balloon (Medtronic).
Interview »
Dr. Tod C. Engelhardt, Discusses Catheter-Directed, Ultrasound-Accelerated Thrombolysis to Treat Pulmonary Embolism
Interview by Amanda Wright
Tell me about your recently published study regarding the use of catheter-directed ultrasound-accelerated thrombolysis for the treatment of pulmonary embolism.
This is a really exciting new thing for me, and actually a new thing for the world for that matter, in the treatment of pulmonary embolism. Pulmonary embolism can be and frequently is a life-threatening condition and we’re taking patients now with a significant clot burden, a significant degree of debility from pulmonary embolism, and treating them with ultrasound-assisted thrombolysis, which means that we are using a drug to dissolve blood clots in combination with ultrasound technology.
